An eight-week, nonpharmacological intervention showed significant relationships with pain and biological outcomes

Increase disproportionately affected children, patients enrolled in Medicaid, and Black individuals

Risk score derived from cardiovascular reactivity predictive of adverse outcomes beyond traditional cardiovascular risk factors in CAD

Despite high use of a device, only one in four shares data with physicians

By India Edwards HealthDay ReporterMONDAY, Feb. 3, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) has taken down multiple health-related websites and datasets, including those on HIV, LGBTQ health and more, following executive orders from the Trump administration.The orders require federal agencies to eliminate diversity, …

U.S. Census sex-age adjustments improved clinical performance estimates

Approval is targeted for patients with HER2-low or HER2-ultralow metastatic breast cancer with disease progression after endocrine therapy

No increase reported in psychotherapy claims during pregnancy; medication fills returned to prepregancy levels within one month after birth

Significantly lower 15-year cumulative incidence of major adverse liver outcomes seen in those undergoing metabolic surgery

By India Edwards HealthDay ReporterFRIDAY, Jan. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.The new pill, developed by Vertex Pharmaceuticals, is intended for short-term pain …